Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression

Focus (Am Psychiatr Publ). 2021 Jan;19(1):76-85. doi: 10.1176/appi.focus.19107. Epub 2021 Jan 25.

Abstract

(Reprinted with permission from Am J Geriatr Psychiatry 2020; 28:933-945).

Keywords: Late-life depression geriatric depression major depressive disorder antidepressant pharmacogenomics clinical trial medication selection.